A stent is a miniature wire mesh tube that is used to treat a blocked passageway to keep it open. The stent improves the blood flow or other fluids flow, subject to its location. The global stent market is estimated at USD7.98 billion in 2016 and is expected to grow at a CAGR of 3.4 percent over the next ten years. Overall stent market is shifting towards the adoption of biodegradable stents that dissolve completely in the blood vessels and eliminate the risk of thrombosis. The key factors driving the growth are growing the aging population, increasing the prevalence of chronic diseases such as metabolic diseases and heart disease, advancement in stent technology, preference for minimally invasive procedures. Vascular stents dominate the total stent market. Among the vascular stents, coronary stent holds the maximum market share due to the presence of major medical devices players, increasing research in cardiology, increasing number of cardiovascular procedures and research and development activities of the players. Neurovascular stents hold the huge potential for growth in the future and is expected to grow at a growth rate of 6 percent over the period 2016 to 2026.
Coronary stents are further classified as Bare Stents (BMS), Drug-Eluting Stents (DES), covered stents, and Bioresorbable Stents (BRS; non-drug eluting and drug-eluting BRS). BMS market is projected to decline over the forecast period at a rate of -3.8 percent due to advantages offered by advanced stent technology. DES has dominated the overall coronary stents market,however, BRS is expected to show the highest growth rate due to the unmet need for dissolvable stents. Unlike the coronary stent market in developing countries, which are still expanding, the coronary stent markets of developed regions are mature. Therefore, a company's success in these regions is determined by developing innovative products that offer significant advantages over the previous versions.
The global market for non-vascular stents is forecasted to grow at a rate of 4.2 percent over the forecast period due to increasing prevalence of Gastrointestinal Cancer, Prostate Cancer and Ureteral Diseases such as Kidney Stones, and Urinary Tract Infection.
North America dominates the overall stent market with 37 percent due to the presence of big players and early introduction of advanced technologies, favorable reimbursement policies and increased prevalence of chronic disease requiring stenting procedures. On the other hand, Asia-Pacific accounts for the maximum market share of coronary stent market owning to the large number of cardiovascular procedures done and the highest number of people suffering from chronic disease coupled with an aging population. Asia-pacific region is expected to maintain the market share over the forecast period despite the high cost of treatment, price cuts by governments and unfavorable reimbursement policies.
Abbott, Boston Scientific Corporation, Medtronic, Elixir Medical, Biotronik,and Terumo are the key players involved in the stent market. In 2016, Abbott, Boston Scientific,and Medtronic, accounted for a major market share of the coronary stent market and making it difficult for emerging players to enter this market.
Key questions answered and insights delivered in the report:
- Global market size of stent; 2016-2026.
- Market size of stentin North America, Europe and Asia specific; 2016-2026.
- Global Market size of vascular stent; 2016-2026.
- Market size of vascular stentin North America, Europe and Asia specific; 2016-2026.
- Global Market size of non-vascular stent; 2016-2026.
- Market size of non-vascular stentin North America, Europe and Asia specific; 2016-2026.
- Global Market size of peripheral stent; 2016-2026.
- Market size of peripheral stent in North America, Europe and Asia specific; 2016-2026.
- Global Market size of coronary stent; 2016-2026.
- Market size of coronary stent in North America, Europe and Asia specific; 2016-2026.
- Global Market size of neurovascular stent; 2016-2026.
- Market size of neurovascular stent in North America, Europe and Asia specific; 2016-2026.
- Product analysis of bare metal stents, drug eluting stents, and bioresorbable stents.
- Detailed analysis of growth drivers, challenges, and trends of stent market.
- Detailed Company Profiling of Key Market Players: Boston Scientific , Medtronic , Abbott, Terumo Corporation, and Elixir Medical.
1. Executive Summary
2. Stent: Overview
I. Evolution of Stents
II. Classification of Stents
a. Coronary Stents
b. Peripheral Stents
c. Neurovascular Stents
3. Stents Market: An Analysis
I. Global Stent Market
a. Global Vascular Stent Market
i. Coronary Stents Market
ii. Peripheral Stents Market
iii. Neurovascular Stents Market
b. Global Non-Vascular Stent Market
II. North America Stent Market
a. North America Vascular Stent Market
i. Coronary Stents Market
ii. Peripheral Stents Market
iii. Neurovascular Stents Market
b. North America Non-Vascular Stent Market
III. Europe Stent Market
a. Europe Vascular Stent Market
i. Coronary Stents Market
ii. Peripheral Stents Market
iii. Neurovascular Stents Market
b. Europe Non-Vascular Stent Market
IV. Asia-Pacific Stent Market
a. Asia-Pacific Vascular Stent Market
i. Coronary Stents Market
ii. Peripheral Stents Market
iii. Neurovascular Stents Market
b. Asia-Pacific Non-Vascular Stent Market
4. Competitive Landscape
5. Product Analysis
I. Coronary Stents
a. Bare Metal Stents
b. Drug Eluting Stents
c. Bioresorbable Stents
II. Peripheral Stents
III. Neurovascular Stents
IV. Non Vascular Stents
6. Patent Landscape
I. Stents Patent Trend by Focus Area
II. Stents Patent Trend by Type
III. Stents Patent Trend by Properties
IV. Key Patents of Stents
V. Patents by Key Players
a. Key Players role in Patent Focus
b. Key Players role in Stent Type
c. Key Players role in Stent Properties
V. Key Inventors
7. Market Dynamics
I. Growth Drivers
a. Aging Population
b. The rise in Prevalence of Chronic Diseases
c. The rise in Adoption of Minimally Invasive Procedures
II. Challenges
a. Stringent Regulations
b. High Cost of Treatment Associated with Stents
c. Availability of Alternative Treatments
d. Chelation Therapy
e. Medications & Healthy Lifestyle
f. Endarterectomy
g. Other Surgical Options
III. Trends
a. Advancements in Stent Material and Drug Coatings
b. Price Control of Stents
8. Company Profiles
I. Boston Scientific
a. Business Overview
b. Financial Overview
c. Business Strategy
II. Medtronic
a. Business Overview
b. Financial Overview
c. Business Strategy
III. Abbott
a. Business Overview
b. Financial Overview
IV. Terumo Corporation
a. Business Overview
b. Financial Overview
c. Business Strategy
V. Elixir Medical
a. Business Overview
b. Financial Overview
9. About EffeMarket
10. Disclaimer
11. Contact US
Figure 1: Advancement in Stents
Figure 2: Classification of Stents
Figure 3: Reasons for Use of BMS rather than DES in PCI
Figure 4: Basic Characteristic of Stent
Figure 5: Global Stent Market by Value; 2016-2026
Figure 6: Pricing Trend in Stents
Figure 7: Global Vascular Stent Market by Value; 2016-2026
Figure 8: Global Coronary Stent Market by Types; 2016-2026
Figure 9: Global Coronary Stent Market by Regions; 2016
Figure 10: Global Coronary Stent Market by Companies; 2016-2026
Figure 11: Global Coronary Stent Market by Companies; 2016-2026
Figure 12: Global Neurovascular Stent Market by Value; 2016-2026
Figure 13: Global Neurovascular Stent Market by Value; 2016-2026
Figure 14: North America Stent Market by Value; 2016-2026
Figure 15: North America Vascular Stent Market by Value; 2016-2026
Figure 16: North America Coronary Stent Market by Value; 2016-2026
Figure 17: North America Peripheral Stent Market by Value; 2016-2026
Figure 18: North America Neurovascular Stent Market by Value; 2016-2026
Figure 19: North America Non-Vascular Stent Market by Value; 2016-2026
Figure 20: Europe Stent Market by Value; 2016-2026
Figure 21: Europe Vascular Stent Market by Value; 2016-2026
Figure 22: Europe Coronary Stent Market by Value; 2016-2026
Figure 23: Europe Peripheral Stent Market by Value; 2016-2026
Figure 24: Europe Neurovascular Stent Market by Value; 2016-2026
Figure 25: Europe Non-Vascular Stent Market by Value; 2016-2026
Figure 26: Asia-Pacific Stent Market by Value; 2016-2026
Figure 27: Asia-Pacific Vascular Stent Market by Value; 2016-2026
Figure 28: Asia-Pacific Coronary Stent Market by Value; 2016-2026
Figure 29: Asia-Pacific Peripheral Stent Market by Value; 2016-2026
Figure 30: Asia-Pacific Neurovascular Stent Market by Value; 2016-2026
Figure 31: Asia-Pacific Non-Vascular Stent Market by Value; 2016-2026
Figure 32: Overall IP Trends in Stents; 2013-2018
Figure 33: Earliest Priority Country Filing Trend in Stents; 2013-2018
Figure 34: Stent Patent Trend by Focus Area; 2013-2018
Figure 35: Stent Patent Trend by Type; 2013-2018
Figure 36: Stent Patent Trend by Properties; 2013-2018
Figure 37: Stent Patent Trend by Key Players; 2013-2018
Figure 38: Stent Patent Trend by Key Inventors 2013-2018
Figure 39: Age Structure of Global Population; 2015-2050
Figure 40: Prevalence of Chronic Disease in the US; 1995-2030
Figure 41: Prevalence of Chronic Disease in the US; 1995-2030
Figure 42: Cost of Angioplasty by Countries; 2016
Figure 43: Boston Scientific Revenue; 2013-2017
Figure 44: Medtronic Revenue; 2013-2017
Figure 45: Abbott Revenue; 2013-2017
Figure 46: Terumo Revenue; 2012-2016
Table 1: Pricing of Stents
Table 2: Stent Patent Trend by Focus Area (Year Wise Filing); 2007-2018
Table 3: Stent Patent Trend by Type (Year Wise Filing); 2007-2018
Table 4: Stent Patent Trend by Properties; 2013-2018
Table 5: Key Patents of Stents; 2013-2018
Table 6: Stent Patent Trend by Key Players Year Wise Patent Publication; 2013-2018
Table 7: Stent Patent Trend by Key Players role in Patent Focus; 2013-2018
Table 8: Stent Patent Trend by Key Players role in Stent Type; 2013-2018
Table 9: Stent Patent Trend by Key Players role in Stent Properties
Table 10: Stent Patent Top Inventors actively associated with the Key Players
Table 11: Competitive Landscape of Major Players
Table 12: Comparison of Key Bare Metal Stents
Table 13: Comparison of Key BRS Technology
Table 14: Key Peripheral Stents
Table 15: Key Neurovascular Stents
Table 16: Key Non-Vascular Stents